Search research articles
Contact Us
Filters
Showing results (121-130 of 143) with videos related to
Page
of 15
Sort By:
Trials
|
January 8, 2020
Vitamin D supplementation compared to placebo in people with First Episode psychosis - Neuroprotection Design (DFEND): a protocol for a randomised, double-blind, placebo-controlled, parallel-group trial
Fiona Gaughran, Dominic Stringer, Michael Berk, et al.
BMC Psychiatry
|
December 24, 2017
Randomised controlled trial to improve health and reduce substance use in established psychosis (IMPaCT): cost-effectiveness of integrated psychosocial health promotion
Margaret Heslin, Anita Patel, Daniel Stahl, et al.
Schizophrenia Bulletin Open
|
September 27, 2021
Development and Validation of a Nonremission Risk Prediction Model in First-Episode Psychosis: An Analysis of 2 Longitudinal Studies
Samuel P Leighton, Rajeev Krishnadas, Rachel Upthegrove, et al.
Psychological Medicine
|
February 5, 2025
Cognitive presentation at psychosis onset through premorbid deterioration and exposure to environmental risk factors
Laura Ferraro, Marta Di Forti, Daniele La Barbera, et al.
Human Molecular Genetics
|
January 15, 2010
A large replication study and meta-analysis in European samples provides further support for association of AHI1 markers with schizophrenia
Andrés Ingason, Ina Giegling, Sven Cichon, et al.
Molecular Psychiatry
|
August 29, 2023
Cortical morphology in patients with the deficit and non-deficit syndrome of schizophrenia: a worldwide meta- and mega-analyses
Nerisa Banaj, Daniela Vecchio, Fabrizio Piras, et al.
Human Molecular Genetics
|
October 24, 2008
Disruption of the neurexin 1 gene is associated with schizophrenia
Dan Rujescu, Andres Ingason, Sven Cichon, et al.
Molecular Psychiatry
|
October 15, 2024
Methylomic signature of current cannabis use in two first-episode psychosis cohorts
Emma L Dempster, Chloe C Y Wong, Joe Burrage, et al.
Psychological Medicine
|
October 17, 2019
An overlapping pattern of cerebral cortical thinning is associated with both positive symptoms and aggression in schizophrenia via the ENIGMA consortium
Ting Yat Wong, Joaquim Radua, Edith Pomarol-Clotet, et al.
Nature
|
August 1, 2008
Large recurrent microdeletions associated with schizophrenia
Hreinn Stefansson, Dan Rujescu, Sven Cichon, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 143) with videos related to
Sort By:
Page
of 15
Trials
|
January 8, 2020
Vitamin D supplementation compared to placebo in people with First Episode psychosis - Neuroprotection Design (DFEND): a protocol for a randomised, double-blind, placebo-controlled, parallel-group trial
Fiona Gaughran, Dominic Stringer, Michael Berk, et al.
BMC Psychiatry
|
December 24, 2017
Randomised controlled trial to improve health and reduce substance use in established psychosis (IMPaCT): cost-effectiveness of integrated psychosocial health promotion
Margaret Heslin, Anita Patel, Daniel Stahl, et al.
Schizophrenia Bulletin Open
|
September 27, 2021
Development and Validation of a Nonremission Risk Prediction Model in First-Episode Psychosis: An Analysis of 2 Longitudinal Studies
Samuel P Leighton, Rajeev Krishnadas, Rachel Upthegrove, et al.
Psychological Medicine
|
February 5, 2025
Cognitive presentation at psychosis onset through premorbid deterioration and exposure to environmental risk factors
Laura Ferraro, Marta Di Forti, Daniele La Barbera, et al.
Human Molecular Genetics
|
January 15, 2010
A large replication study and meta-analysis in European samples provides further support for association of AHI1 markers with schizophrenia
Andrés Ingason, Ina Giegling, Sven Cichon, et al.
Molecular Psychiatry
|
August 29, 2023
Cortical morphology in patients with the deficit and non-deficit syndrome of schizophrenia: a worldwide meta- and mega-analyses
Nerisa Banaj, Daniela Vecchio, Fabrizio Piras, et al.
Human Molecular Genetics
|
October 24, 2008
Disruption of the neurexin 1 gene is associated with schizophrenia
Dan Rujescu, Andres Ingason, Sven Cichon, et al.
Molecular Psychiatry
|
October 15, 2024
Methylomic signature of current cannabis use in two first-episode psychosis cohorts
Emma L Dempster, Chloe C Y Wong, Joe Burrage, et al.
Psychological Medicine
|
October 17, 2019
An overlapping pattern of cerebral cortical thinning is associated with both positive symptoms and aggression in schizophrenia via the ENIGMA consortium
Ting Yat Wong, Joaquim Radua, Edith Pomarol-Clotet, et al.
Nature
|
August 1, 2008
Large recurrent microdeletions associated with schizophrenia
Hreinn Stefansson, Dan Rujescu, Sven Cichon, et al.
Page
of 15